MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202421010386 A) filed by Bharat Serums And Vaccines Ltd., Navi Mumbai, Maharashtra, on Feb. 14, 2024, for 'purification process and formulation of recombinant anti rhd monoclonal antibodies.'
Inventor(s) include Mr. Mahesh Gavasane; Mr. Pranav Gupte; Mr. Lilesh Bhise; Mr. Tushar Bhabal; Ms. Aditee Kambli; and Dr. Abir Banerjee.
The application for the patent was published on Aug. 22, under issue no. 34/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to an improved purification process for isolating anti-Rhesus D monoclonal antibodies and their antigen-binding fragments. The improved process involves a series of purification techniques, including affinity chromatography, low pH inactivation, anion exchange and cation exchange chromatography, virus/nanofiltration, ultrafiltration and the like. The present invention also encompasses a stable formulation for the purified antibodies or fragments with improved shelf life and performance of the final product."
Disclaimer: Curated by HT Syndication.
